People, every show

Jennifer Lynn

Founder and CEO, Ashlins Pharmaceuticals. On 1 show, 1 appearance. The Shows tab opens the full record on each.

founderexecutiveashlinspharma.com ↗

Jennifer Lin is a Thiel Fellow and biotechnology entrepreneur dedicated to developing and repurposing therapies for rare diseases. After establishing AUG Therapeutics to advance late-stage candidates for leukocyte adhesion deficiency type II, she founded Ashlins Pharmaceuticals to in-license clinically validated assets for formal FDA approval.

What they said2 Shows1

Everything Jennifer Lynn said on any show that made the record, most notable first. Each card names its show and opens the statement there.

TBPN Assertion Supported

New FDA Guidance Reduces Animal Testing Requirements for Antibody Biologics

“So they just recently released the guidance that certain biologic drugs, antibodies don't have to go after as much animal testing. You can leverage a lot of human clinical trials, which is like almost incorporating common sense, right?”

Jennifer Lynn May 28, 2025 ▶ 1:20:37 We Interviewed the New Thiel Fellow Dropouts

TBPN Insight

Repurposing Off-Patent Drugs Derisks Safety Hurdles for Rare Diseases

“Repurposing old drugs is a great strategy because you have safety usually already established for patients. Now you just have to work on making sure that it's like a drug that works.”

Jennifer Lynn May 28, 2025 ▶ 1:18:11 We Interviewed the New Thiel Fellow Dropouts

One line per show, most statements first. The link opens Jennifer's full record on that show: the calibration, argument clarity, speaking style and every statement made there.

Show	Role there	Eps	Statements	Record
TBPNLEDGER	Founder and CEO, Ashlins Pharmaceuticals	1	2	100% 1/1	full record on TBPN →